Live attenuated viral vaccines for Eastern equine encephalitis virus
AssigneeThe United States of America as represented by the Secretary of the Army
InventorsPeter L. Platteborze, Michael D. Parker
Life of this patent
Estimating the term…
Abstract
Live attenuated Eastern Equine Encephalitis (EEE) vaccines that outperform the PE-6 vaccine in mice aerosol challenged with >1,000×LD50. Candidates include four furin-cleavage deletion mutants and one E3 deletion mutant. Each vaccine provided protection in birds against antigenically distinct North and South American strains of EEE. The PE-6 vaccine does not provide protection against South American EEEs. Animals inoculated with each of the vaccines of the invention developed neutralizing antibodies to EEE.
Claims78
A DNA comprising an isolated and purified eastern equine encephalitis (EEE) virus cDNA fragment coding for infectious eastern equine encephalitis virus genome.
A DNA comprising an isolated and purified eastern equine encephalitis virus DNA coding for FL91-4679.
A live attenuated eastern equine encephalitis virus vaccine comprising one or more of the candidates selected from the group consisting of (1) a DNA comprising an isolated and purified eastern equine encephalitis virus cDNA fragment coding for infectious eastern equine encephalitis virus genome, wherein said cDNA fragment contains a deletion in the furin cleavage site and one or more suppressor mutations, (2) a DNA comprising an isolated and purified eastern equine encephalitis virus cDNA fragment coding for infectious eastern equine encephalitis virus genome, wherein said cDNA fragment contains a partial deletion of the furin cleavage site and one or more suppressor mutations, and (3) a DNA comprising an isolated and purified eastern equine encephalitis virus cDNA fragment coding for infectious eastern equine encephalitis virus genome, wherein said cDNA fragment contains a four amino acid deletion from codons 21-24 of the E3 gene.
A live attenuated eastern equine encephalitis virus vaccine comprising one or more DNA comprising an isolated and purified eastern equine encephalitis virus cDNA fragment coding for infectious eastern equine encephalitis virus genome, wherein said one or more DNA is selected from the group consisting of:
- (1) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of an aspartic acid at codon 174 of E2 gene to an alanine, (2) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of a lysine at codon 186 of E2 gene to an asparagines, (3) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of an isoleucine at codon 116 of E1 gene to a threonine, (4) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of a histidine at codon 82 of E2 gene to an arginine, (5) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of an asparagines at codon 230 of E2 gene to a serine, (6) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of a praline at codon 303 of E2 gene to a glutamine, (7) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of an isoleucine at codon 116 of E1 gene to an aspargagine, (8) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a deletion of a histidine at codon 167 of E2 gene, (9) wherein said cDNA fragment contains a partial deletion of the furin cleavage site and a suppressor mutation of a substitution of a histidine at codon 82 of E2 gene to an arginine, (10) wherein said cDNA fragment contains a partial deletion of the furin cleavage site and a suppressor mutation of a deletion of a histidine at codon 167 of E2 gene, (11) wherein said cDNA fragment contains a partial deletion of the furin cleavage site and a suppressor mutation of a substitution of an arginine at codon 59 of E3 gne to a serine, (12) wherein said cDNA fragment contains a partial deletion of the furin cleavage site and a suppressor mutation of a substitution of an asparagines at codon 80 of E2 gene to an aspartic acid, and (13) wherein said cDNA fragment contains a four amino acid deletion from codons 21-24 in an E3 gene.
Dependencies are inferred from the claim text.